1887

Journal of Medical Microbiology logo

Volume 59, Issue 9

Clonal spread of CTX-M-15-producing in a Croatian hospital Free

Abstract

This study was conducted to detect and analyse the presence of extended-spectrum -lactamase (ESBL)-producing associated with a nosocomial outbreak at a Croatian hospital. During 2007, 162 isolates with reduced susceptibility to third-generation cephalosporins were collected from various hospital units and patient specimens. Most of the strains were isolated from urine (61 %), followed by blood cultures (13 %), wound swabs (13 %), tracheal aspirates (5 %), intra-abdominal abscess aspirates (4 %), intravascular catheters (3 %) and cerebrospinal fluid (1 %). Medical wards were the most important source of the isolates (46 %); 21 % of the isolates originated from surgical intensive-care units. All patients had infections acquired during their stay in hospital. No community-acquired infections were reported. Sixty of these isolates were chosen for further analysis. A double-disc synergy test (DDST) was used to detect ESBLs. MICs were determined by the broth microdilution method according to CLSI guidelines. The transferability of ceftazidime resistance was tested by conjugation (broth mating method). PCR was used to detect alleles encoding ESBL enzymes. Plasmids encoding ESBLs were extracted with the Macherey Nagel Mini kit according to the manufacturer's recommendations. The genotypes of the strains were compared by analysis of banding patterns generated by PFGE of I-digested genomic DNA. ESBLs were found by DDST in all isolates. All strains were resistant to cefuroxime, ceftazidime, cefotaxime, ceftriaxone, aztreonam, piperacillin/tazobactam and ciprofloxacin. There was variable susceptibility/resistance to cefepime and gentamicin. No resistance to ceftazidime/clavulanate and carbapenems was observed. Only six strains transferred resistance to an recipient strain, with low frequency. All isolates yielded an amplicon of 545 bp with consensus MA primers. Multiplex PCR was positive for group 1 CTX-M -lactamases. Sequencing of selected amplicons revealed the presence of , with coding regions containing identical nucleotide sequences. Similarly to isolates from India, our isolates contained the IS insertion sequence located upstream of the gene, which has recently been demonstrated to mobilize 3′-adjacent genes to transfer between DNA replicons. The isolates contained a large plasmid of approximately 150 kb. The isolates were assigned to five clusters (>85 % similarity), which contained subclusters. The results of this work provided insights into the molecular epidemiology of the spread of ESBLs in involved in an outbreak at a Croatian hospital. The hospital antibiotic policy resulted in ceftriaxone being the most heavily prescribed third-generation cephalosporin, which might be expected to select for cefotaximases such as CTX-M-15.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): DDD, defined daily dosis , DDST, double-disc synergy test and ESBL, extended-spectrum β-lactamase
SGM
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.019778-0
2010-09-01
2024-04-20
Loading full text...

Full text loading...

/deliver/fulltext/jmm/59/9/1069.html?itemId=/content/journal/jmm/10.1099/jmm.0.019778-0&mimeType=html&fmt=ahah

References

  1. Arlet G., Brami G., Decre D., Flippo A., Gaillot O., Lagrange P. H., Philippon A. 1995; Molecular characterization by PCR-restriction fragment polymorphism of TEM beta-lactamases. FEMS Microbiol Lett 134:203–208
     [Google Scholar]
  2. Baraniak A., Fiett J., Sulikowska A., Hryniewicz W., Gniadkowski M. 2002; Countrywide spread of CTX-M-3 extended-spectrum beta-lactamase-producing microorganisms of the family Enterobacteriaceae in Poland. Antimicrob Agents Chemother 46:151–159 [CrossRef]
     [Google Scholar]
  3. Bedenic B., Zagar Z. 1998; Extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae from Zagreb, Croatia. J Chemother 10:449–459 [CrossRef]
     [Google Scholar]
  4. Bedenic B., Randegger C., Stobberingh E., Hachler H. 2001; Molecular epidemiology of extended-spectrum beta-lactamases from Klebsiella pneumoniae strains isolated in Zagreb, Croatia. Eur J Clin Microbiol Infect Dis 20:505–508 [CrossRef]
     [Google Scholar]
  5. Bedenic B., Schmidt H., Herold S., Monaco M., Plečko V., Kalenic S., Katic S., Skrlin-Subic J. 2005; Epidemic and endemic spread of Klebsiella pneumoniae producing SHV-5 beta-lactamase in Dubrava University Hospital, Zagreb. J Chemother 17:367–375 [CrossRef]
     [Google Scholar]
  6. Bonnet R. 2004; Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 48:1–14 [CrossRef]
     [Google Scholar]
  7. Bradford P. A. 2001; Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 14:933–951 [CrossRef]
     [Google Scholar]
  8. Bradford P. A., Yang Y., Sahm D., Grope I., Gardovska D., Storch D. 1998; CTX-M-5, a novel cefotaxime-hydrolyzing beta-lactamase from an outbreak of Salmonella typhimurim in Latvia. Antimicrob Agents Chemother 42:1980–1984
     [Google Scholar]
  9. Cantón R., Oliver A., Coque T. M., Varela M. del C., Pérez-Díaz J. C., Baquero F. 2002; Epidemiology of extended-spectrum β -lactamase-producing Enterobacter isolates in a Spanish hospital during a 12-year period. J Clin Microbiol 40:1237–1243 [CrossRef]
     [Google Scholar]
  10. Chanawong A., M'Zali F. H., Heritage J., Xiong J. H., Hawkey P. M. 2002; Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14 among Enterobacteriaceae in the People's Republic of China. Antimicrob Agents Chemother 46:630–637 [CrossRef]
     [Google Scholar]
  11. CLSI 2007; Performance standards for antimicrobial susceptibility testing , 17th informational supplement. CLSI/NCCLS document M100-S17. Wayne, PA: Clinical and Laboratory Standards Institute;
  12. Damjanova I., Toth A., Paszti J., Hajbel-Vekony G., Jakab M., Berta J., Milich H., Fuzi M. 2008; Expansion and countrywide dissemination of ST11, ST15, and ST147 ciprofloxacin-resistant CTX-M-15-type β -lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005 – the new ‘MRSAs'?. J Antimicrob Chemother 62:978–985 [CrossRef]
     [Google Scholar]
  13. Eckert C., Gautier V., Saladin-Allard M., Hidri N., Verdet C., Ould-Hocine Z., Barnaud G., Delisle F., Rossier A. other authors 2004; Dissemination of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother 48:1249–1255 [CrossRef]
     [Google Scholar]
  14. Edelstein M., Pimkin M., Palagin I., Edelstein I., Stratchounski L. 2003; Prevalence and molecular epidemiology of CTX-M extended spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrob Agents Chemother 47:3724–3732 [CrossRef]
     [Google Scholar]
  15. Eisner A., Fagan E. J., Feierl G., Kessler H. H., Marth E., Livermore D. M., Woodford N. 2006; Emergence of Enterobacteriaceae isolates producing CTX-M extended-spectrum beta-lactamase in Austria. Antimicrob Agents Chemother 50:785–787 [CrossRef]
     [Google Scholar]
  16. Elwell L. P., Falkow S. 1986; The characterization of R plasmids and the detection of plasmid-specified genes. In Antibiotics in Laboratory Medicine , 2nd edn. pp 683–721 Edited by Lorian V. Baltimore: Williams & Wilkins;
     [Google Scholar]
  17. Jacoby G. A., Munoz-Price L. S. 2005; The new beta-lactamases. N Engl J Med 352:380–391 [CrossRef]
     [Google Scholar]
  18. Jarlier V., Nicolas M. H., Fournier G., Philippon A. 1988; Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae : hospital prevalence and susceptibility patterns. Rev Infect Dis 10:867–878 [CrossRef]
     [Google Scholar]
  19. Karim A., Poirel L., Nagarajan S., Nordmann P. 2001; Plasmid-mediated extended-spectrum beta-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1. FEMS Microbiol Lett 201:237–241
     [Google Scholar]
  20. Kaufman M. E. 1998; Pulsed-field gel electrophoresis. In Molecular Bacteriology Protocols and Clinical Applications pp 33–51 Edited by Woodford N., Johnson A. Totowa, NJ: Humana Press;
     [Google Scholar]
  21. Kiratisin P., Apisarnthanarak A., Saifon P., Laesripa C., Kitphati R., Mundy L. M. 2007; The emergence of a novel ceftazidime-resistant CTX-M extended-spectrum beta-lactamase, CTX-M-15, in both community-onset and hospital-acquired infections in Thailand. Diagn Microbiol Infect Dis 58:349–355 [CrossRef]
     [Google Scholar]
  22. Kliebe C., Nies B. A., Meyer J. F., Toixdorf-Neutzling R. M., Wiedemann B. 1985; Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrob Agents Chemother 28:302–307 [CrossRef]
     [Google Scholar]
  23. Lartigue M. F., Zinsius C., Wenger A., Bille J., Poirel L., Nordmann P. 2007; Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland. Antimicrob Agents Chemother 51:2855–2860 [CrossRef]
     [Google Scholar]
  24. Lavigne J. P., Marchandin H., Delmas J., Bouziges N., Lecaillon E., Cavalie L., Jean-Pierre H., Bonnet R., Sotto A. 2006; qnrA in CTX-M producing Escherichia coli isolates from France. Antimicrob Agents Chemother 50:4224–4228 [CrossRef]
     [Google Scholar]
  25. Lee J., Pai H., Kim N. H., Eun B. W., Kang H. J. K., Park K. H., Choi E. H., Shin H. Y., Kim E. C. other authors 2007; Control of extended-spectrum β -lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy. J Antimicrob Chemother 60:629–637 [CrossRef]
     [Google Scholar]
  26. Literacka E., Bedenic B., Baraniak A., Fiett J., Tonkic M., Jajic-Bencic I., Gniadkowski M. 2009; bla CTX-M genes in Escherichia coli from Croatian hospitals are located in new ( bla CTX-M-3a) and widely spread ( bla CTX-M-3a and bla CTX-M-15) genetic structures. Antimicrob Agents Chemother 53:1630–1635 [CrossRef]
     [Google Scholar]
  27. Livermore D. M., Cantón R., Gniadkowski M., Nordmann P., Rossolini G. M., Arlet G., Ayala J., Coque T. M., Kern-Zdanowicz I. other authors 2007; CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 59:165–174
     [Google Scholar]
  28. Markovska R., Schneider I., Keuleyan E., Bauernfeind A. 2004; Extended-spectrum beta-lactamase (ESBL) CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae in Sofia, Bulgaria. Clin Microbiol Infect 10:752–755 [CrossRef]
     [Google Scholar]
  29. Mena A., Plascencia V., Garcia L., Hidalgo O., Ayestaran J. I., Alberti S., Borrell N., Perez J. L., Oliver A. 2006; Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development. J Clin Microbiol 44:2831–2837 [CrossRef]
     [Google Scholar]
  30. Meško Meglič K., Koren S., Palepou M. F. I., Karisik E., Livermore D. M., Pike R., Andolovic A., Jeverica S., Križan-Hergouth V. other authors 2009; Nationwide survey of CTX-M-type extended-spectrum β -lactamases among Klebsiella pneumoniae isolates in Slovenian hospitals. Antimicrob Agents Chemother 53:287–291 [CrossRef]
     [Google Scholar]
  31. Mugnaioli C., Luzzaro F., De Luca F., Brigante G., Perilli M., Amicosante G., Stefani S., Toniolo A., Rossolini G. M. 2006; CTX-M-type extended-spectrum beta-lactamases in Italy: molecular epidemiology of an emerging countrywide problem. Antimicrob Agents Chemother 50:2700–2706 [CrossRef]
     [Google Scholar]
  32. Nüesch-Inderbinen M. T., Hachler H., Kayser F. H. 1996; Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test. Eur J Clin Microbiol Infect Dis 15:398–402 [CrossRef]
     [Google Scholar]
  33. Oteo J., Navarro C., Cercenado E., Delgrado-Iribarren A., Wilhelmi I., Orden B, García C, Miguelañez S, Pérez-Vázquez M. other authors 2006; Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term facilities, and hospital institutions. J Clin Microbiol 44:2359–2366 [CrossRef]
     [Google Scholar]
  34. Oteo J., Cuevas O., López-Rodrígez I., Banderas-Florido A., Vindel A., Pérez-Vázquez M., Bautista V., Arroyo M., García-Cabellero J. other authors 2009; Emergence of CTX-M-15-producing Klebsiella pneumoniae of multilocus sequence types 1, 11, 14, 17, 20, 35 and 36 as pathogens and colonizers in newborns and adults. J Antimicrob Chemother 64:524–528 [CrossRef]
     [Google Scholar]
  35. Pagani L., Mantengoli E., Migliavacca R., Nucleo E., Pollini S., Spalla M., Daturi R., Romero E., Rossolini G. M. 2004; Multifocal detection of multidrug-resistant Pseudomonas aeruginosa producing PER-1 extended-spectrum beta-lactamase in Northern Italy. J Clin Microbiol 42:2523–2529 [CrossRef]
     [Google Scholar]
  36. Palucha A., Mikiewicz B., Hryniewicz W., Gniadkowski M. 1999; Concurrent outbreaks of extended-spectrum beta-lactamase-producing organisms of the family Enterobacteriaceae in a Warsaw hospital. J Antimicrob Chemother 44:489–499 [CrossRef]
     [Google Scholar]
  37. Pitout J. D., Nordmann P., Laupland K. B., Poirel L. 2005; Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases in the community. J Antimicrob Chemother 56:52–59 [CrossRef]
     [Google Scholar]
  38. Pournaras S., Ikonomidis A., Kristo I., Tsakris A., Maniatis A. N. 2004; CTX-M enzymes are the most common extended-spectrum beta-lactamases among Escherichia coli in a tertiary Greek hospital. J Antimicrob Chemother 54:574–575 [CrossRef]
     [Google Scholar]
  39. Quinteros M., Radice M., Gardella N., Rodriguez M. M., Costa N., Korbenfeld D., Couto E., Gutkind G. Microbiology Study Group 2003; Extended-spectrum beta-lactamases in Buenos Aires, Argentina, public hospitals. Antimicrob Agents Chemother 47:2864–2867 [CrossRef]
     [Google Scholar]
  40. Robicsek A., Jacoby G. A., Hooper D. C. 2006a; The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis 6:629–640 [CrossRef]
     [Google Scholar]
  41. Robicsek A., Strahilevitz J., Sahm D. F., Jacoby G. A., Hooper D. C. 2006b; qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob Agents Chemother 50:2872–2874 [CrossRef]
     [Google Scholar]
  42. Saladin M., Cao V. T., Lambert T., Donay J. L., Herrmann J. L., Ould-Hocine Z., Verdet C., Delisle F., Philippon A., Arlet G. 2002; Diversity of CTX-M beta-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol Lett 209:161–168
     [Google Scholar]
  43. Tenover F. C., Arbeit R. D., Goering R. V., Mickelsen P. A., Murray B. E., Persing D. H., Swaminathan B. 1995; Interprinting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233–2239
     [Google Scholar]
  44. Tonkic M., Bedenic B., Goic-Barisic I., Katic S., Kalenic S., Kaufmann M. E., Woodford N., Punda-Polic V. 2007; First report of CTX-M producing isolates from Croatia. J Chemother 19:97–100 [CrossRef]
     [Google Scholar]
  45. Winstanley T. G., Ridgway E. J., Parys B. T., Woodford N., Ward E., Livermore D. M. 2004; First isolation of CTX-M-3 beta-lactamase producer in the United Kingdom. Int J Antimicrob Agents 24:625–627 [CrossRef]
     [Google Scholar]
  46. Woodford N., Ward M. E., Kaufmann M. E., Turton J., Fagan E. J., James D., Johnson A. P., Pike R., Warner M. other authors 2004; Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother 54:735–743 [CrossRef]
     [Google Scholar]
  47. Woodford N., Ellington M. J., Coelho J., Turton J., Ward M. E., Brown S., Amyes S. G. B., Livermore D. M. 2006; Multiplex PCR for genes encoding prevalent OXA carbapenemases. Int J Antimicrob Agents 27:351–353 [CrossRef]
     [Google Scholar]
  48. Yamasaki K., Komatsu M., Yamashita T., Shimakawa K., Ura T., Nishio H., Satoh K., Washidu R., Kinoshita S., Aihara M. 2003; Production of CTX-M-3 extended-spectrum beta-lactamase and IMP-1 metallo- β -lactamase by five Gram-negative bacilli: survey of clinical isolates from seven laboratories collected in 1998 and 2000, in the Kinki region of Japan. J Antimicrob Chemother 51:631–638 [CrossRef]
     [Google Scholar]
  49. Yu W. L., Winokur P., Von Stein D. L. 2002; First description of Klebsiella pneumoniae harboring CTX-M- β -lactamases (CTX-M-14 and CTX-M-3) in Taiwan. Antimicrob Agents Chemother 46:1098–1100 [CrossRef]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.019778-0
Loading
Clonal spread of CTX-M-15-producing Klebsiella pneumoniae in a Croatian hospital
J. Med. Microbiol. 59, 1069 (2010); https://doi.org/10.1099/jmm.0.019778-0
/content/journal/jmm/10.1099/jmm.0.019778-0
/content/journal/jmm/10.1099/jmm.0.019778-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error